Q3 2023 Holdings
Filed 2023-11-14 | 11 holdings | $742.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alkermes PLC(ALKS) | SHS | G01767105 | $197.3M | 7,042,200 | 26.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $165.3M | 643,000 | 22.3% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $157.8M | 16,390,000 | 21.3% |
| Innoviva Inc(INVA) | COM | 45781M101 | $94.5M | 7,277,000 | 12.7% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $69.0M | 920,400 | 9.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $41.2M | 366,000 | 5.5% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $9.6M | 10,442,453 | 1.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.5M | 775,000 | 0.7% |
| VOR Biopharma Inc | COM | 929033108 | $1.3M | 618,000 | 0.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $698.5K | 550,000 | 0.1% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $253.7K | 185,183 | 0.0% |